메뉴 건너뛰기




Volumn 18, Issue 1, 2010, Pages 64-65

Bilateral toxoplasma retinochoroiditis in a patient with chronic myeloid leukemia treated with imatinib mesylate

Author keywords

Chronic myeloid leukemia; Imatinib; Retinochoroiditis; Toxoplasma gondii

Indexed keywords

ABELSON KINASE; BCR ABL PROTEIN; COTRIMOXAZOLE; IMATINIB; IMMUNOGLOBULIN G; PREDNISOLONE;

EID: 76749132575     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273940903315792     Document Type: Article
Times cited : (5)

References (5)
  • 1
    • 0032869930 scopus 로고    scopus 로고
    • Reconsidering the pathogenesis of ocular toxoplasmosis
    • Holland GN. Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol. 1999;128:502-505.
    • (1999) Am J Ophthalmol , vol.128 , pp. 502-505
    • Holland, G.N.1
  • 2
    • 0035186056 scopus 로고    scopus 로고
    • Ocular manifestations of leukemia: Leukemic infiltration versus infectious process
    • Gordon KB, Rugo HS, Duncan JL, et al. Ocular manifestations of leukemia: Leukemic infiltration versus infectious process. Ophthalmology. 2001:108:2293-2300.
    • (2001) Ophthalmology , vol.108 , pp. 2293-2300
    • Gordon, K.B.1    Rugo, H.S.2    Duncan, J.L.3
  • 3
    • 10744233716 scopus 로고    scopus 로고
    • Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia
    • O'Brien SG, Guilhot F, Larson RA, et al. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med. 2003:348:994-1004.
    • (2003) N Engl J Med , vol.348 , pp. 994-1004
    • O'Brien, S.G.1    Guilhot, F.2    Larson, R.A.3
  • 4
    • 61649085306 scopus 로고    scopus 로고
    • Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia
    • Daniels JM, Vonk-Noordegraaf A, Janssen JJ, et al. Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia. Eur Respir J. 2009:33:670-672.
    • (2009) Eur Respir J , vol.33 , pp. 670-672
    • Daniels, J.M.1    Vonk-Noordegraaf, A.2    Janssen, J.J.3
  • 5
    • 15244351682 scopus 로고    scopus 로고
    • Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner
    • Seggewiss R, Loré K, Greiner E, et al. Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner. Blood. 2005:105:2473-2479.
    • (2005) Blood , vol.105 , pp. 2473-2479
    • Seggewiss, R.1    Loré, K.2    Greiner, E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.